
Biopharma firm Spring Bank Pharmaceuticals has revealed it has taken the decision to terminate all further development of inarigivir soproxil …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

